NanoString NSTG Stock
NanoString Price Chart
NanoString NSTG Financial and Trading Overview
NanoString stock price | 0.11 USD |
Previous Close | 0.17 USD |
Open | 0.13 USD |
Bid | 0 USD x 0 |
Ask | 0 USD x 0 |
Day's Range | 0.1 - 0.14 USD |
52 Week Range | 0.04 - 11.02 USD |
Volume | 21.43M USD |
Avg. Volume | 17.91M USD |
Market Cap | 5.07M USD |
Beta (5Y Monthly) | 1.243 |
PE Ratio (TTM) | N/A |
EPS (TTM) | 0 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | 0.25 USD |
NSTG Valuation Measures
Enterprise Value | 154.02M USD |
Trailing P/E | N/A |
Forward P/E | -0.06343374 |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 0.031185841 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 0.948 |
Enterprise Value/EBITDA | -1.037 |
Trading Information
NanoString Stock Price History
Beta (5Y Monthly) | 1.243 |
52-Week Change | -99.21% |
S&P500 52-Week Change | 24.35% |
52 Week High | 11.02 USD |
52 Week Low | 0.04 USD |
50-Day Moving Average | 0.4 USD |
200-Day Moving Average | 2.15 USD |
NSTG Share Statistics
Avg. Volume (3 month) | 17.91M USD |
Avg. Daily Volume (10-Days) | 5.19M USD |
Shares Outstanding | 48.12M |
Float | 39.41M |
Short Ratio | 6.63 |
% Held by Insiders | 3.16% |
% Held by Institutions | 106.45% |
Shares Short | 6.04M |
Short % of Float | 16.66% |
Short % of Shares Outstanding | 12.55% |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2022 |
Most Recent Quarter (mrq) | September 30, 2023 |
Next Fiscal Year End | December 31, 2023 |
Profitability
Profit Margin | -102.43% |
Operating Margin (ttm) | -75.83% |
Gross Margin | 35.72% |
EBITDA Margin | -91.39% |
Management Effectiveness
Return on Assets (ttm) | -30.87% |
Return on Equity (ttm) | -1028.55% |
Income Statement
Revenue (ttm) | 162.47M USD |
Revenue Per Share (ttm) | 3.44 USD |
Quarterly Revenue Growth (yoy) | 62.79% |
Gross Profit (ttm) | 58.04M USD |
EBITDA | -148488992 USD |
Net Income Avi to Common (ttm) | -166431008 USD |
Diluted EPS (ttm) | -3.53 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 97.1M USD |
Total Cash Per Share (mrq) | 2.02 USD |
Total Debt (mrq) | 247.7M USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 2.732 |
Book Value Per Share (mrq) | -1.051 |
Cash Flow Statement
Operating Cash Flow (ttm) | -114977000 USD |
Levered Free Cash Flow (ttm) | -81480752 USD |
Profile of NanoString
Country | United States |
State | WA |
City | Seattle |
Address | 530 Fairview Avenue North |
ZIP | 98109 |
Phone | 206 378 6266 |
Website | https://www.nanostring.com |
Industry | Medical Instruments & Supplies |
Sector(s) | Healthcare |
Full Time Employees | 550 |
NanoString Technologies, Inc. develops, manufactures, and sells technology for scientific and clinical information in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter Pro and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from samples by taking images of the immobilized fluorescent reporters in the sample cartridge and processing the data into output files. The company also offers nCounter SPRINT Profiler, an instrument that provides liquid handling steps and the digital analysis through use of a microfluidic cartridge; and nSolver Analysis Software, a data analysis program that enables researchers to check, normalize, and analyze their data. In addition, it provides custom CodeSets; panels with oncology, immunology and infectious disease, and neuroscience applications. Further, the company offers Master Kits, cartridges, ancillary reagents, tips and reagent plates to setup and process samples in instruments; and Prosigna in vitro diagnostic kits. The company is also developing GeoMx DSP system to enable the field of spatial biology. It has collaboration with Lam Research Corporation for the development of NGS sequencing platform and related assays; and Parker Institute for Cancer Immunotherapy to develop CAR-T regimens that enhances patient outcomes for various types of cancer, as well as collaboration with Stanford Medicine, Acrobat Genomics, and Illumina Accelerator to discover new drug targets for gene editing-based therapeutics. NanoString Technologies, Inc. was incorporated in 2003 and is headquartered in Seattle, Washington. On February 4, 2024, NanoString Technologies, Inc., along with its affiliates, filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Delaware.
Q&A For NanoString Stock
What is a current NSTG stock price?
NanoString NSTG stock price today per share is 0.11 USD.
How to purchase NanoString stock?
You can buy NSTG shares on the NasdaqGM exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for NanoString?
The stock symbol or ticker of NanoString is NSTG.
Which industry does the NanoString company belong to?
The NanoString industry is Medical Instruments & Supplies.
How many shares does NanoString have in circulation?
The max supply of NanoString shares is 0.
What is NanoString Price to Earnings Ratio (PE Ratio)?
NanoString PE Ratio is now.
What was NanoString earnings per share over the trailing 12 months (TTM)?
NanoString EPS is 0 USD over the trailing 12 months.
Which sector does the NanoString company belong to?
The NanoString sector is Healthcare.
NanoString NSTG included in indexes
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
---|
Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
---|---|---|---|---|---|---|---|
{{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
NASDAQ Composite IXIC | 15574.35 USD — |
-0.09
|
6.67B USD — | 14784.03 USD — | 16292.28 USD — | — - | 6.67B USD — |
NASDAQ Biotechnology Total Retu XNBI | 4143.23 USD — |
-1.92
|
— — | 4004.28 USD — | 4291.75 USD — | — - | — — |
NASDAQ Global Market Composite NQGM | 1635.49 USD — |
-0.75
|
— — | 1547.55 USD — | 1705.12 USD — | — - | — — |
NASDAQ Biotechnology NBI | 3839.81 USD — |
-1.65
|
— — | 3700.88 USD — | 3966.57 USD — | — - | — — |
NASDAQ HealthCare IXHC | 863.86 USD — |
-0.68
|
— — | 828.4 USD — | 890 USD — | — - | — — |
NASDAQ Composite Total Return I XCMP | 19020.54 USD — |
-0.31
|
— — | 18095.83 USD — | 19941.93 USD — | — - | — — |
Stlmt ID NASDAQ Biotechnology NBX | 4153.28 USD — |
+1.21
|
— — | 4281.91 USD — | 4648.11 USD — | — - | — — |
- {{ link.label }} {{link}}